Navigation Links
Hyaluron Contract Manufacturing Named a 2007 Economic Impact Award Finalist

HCM recognized by Massachusetts Alliance for Economic Development on the

basis of its strong contribution to Massachusetts economy

BURLINGTON, Mass., Sept. 10 /PRNewswire/ -- Hyaluron Contract Manufacturing (HCM), a leading provider of aseptic manufacturing services to companies in the pharmaceutical and biotechnology industries, announced today that it has been selected as a finalist for the 2007 Team Massachusetts Economic Impact Award. HCM is one of five companies from the greater Boston area that is being considered for this award based on its strong contribution to the Massachusetts economy since January 1, 2006.

"We are extremely pleased to be among the finalists for this award," stated Shawn Kinney, President of HCM. "To be considered along with some of the other finalists as well as past winners is quite an honor for us."

Since January of 2006, HCM has experienced significant growth, making it one of the fastest growing biotech manufacturers in the Commonwealth. In that time, HCM has invested over 2.25 million in facility expansion and has created nearly forty new jobs bringing its current headcount to eighty-five. In October of 2006, the company applied for a patent on its unique Bubble-free filling(TM) technology designed to reduce or eliminate the bubble inside a prefilled syringe.

HCM's future plans include the expansion of its current facility by at least 6,000 square feet and the addition of several new jobs, bringing the total number of employees to 100 by the end of 2007.

In its fourth year, the Team Massachusetts Economic Impact Award recognizes companies from across the Commonwealth for their outstanding contribution to the Massachusetts economy based on job and facility expansion as well as product launch and community involvement. Past winners include Boston Scientific, Bayer Diagnostics, and Wyeth Biopharmaceuticals.

About HCM:

Hyaluron Contract Manufacturing (HCM) is a leader in aseptic contract manufacturing of filled liquid parenterals and medical devices. Since 1999, HCM has been offering its customers-from newly established firms to large- scale commercial enterprises-innovative and unique solutions to all their aseptic formulation/fill needs. At the core of HCM's business is a commitment to quality, regulatory compliance and on-time delivery. HCM is located in Burlington MA. For further information, visit

Hyaluron Contract Manufacturing, Inc.

99 South Bedford Street

Burlington, MA 01803

Contact: Claudio Tracanna

Office Phone 781-270-7900 x 114

Cell Phone: 781-443-2850


SOURCE Hyaluron Contract Manufacturing, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Small Tree Communications awarded $2.85M defense contract
2. Research consortium aims to bring security and defense contracts to Wisconsin
3. Johnson Controls unit lands contract for plug-in hybrid battery
4. Johnson Controls partnership wins new contract
5. Defense contract helps Plexus gain record profits
6. Orbitec will use $25 million Air Force contract to make small launch vehicle
7. WHIE receives state eHealth Initiative contract
8. State defensive on new Oracle contract
9. Fisher Biosciences contracts with Madison-based GenTel BioSurfaces
10. School districts contract with Lawson for new data processing software
11. Doyle says new contracts saving state more than $16 million annually
Post Your Comments:
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
(Date:6/23/2016)... -- The Biodesign Challenge (BDC), a university competition that asks ... systems and biotechnology, announced its winning teams at the ... York City . The teams, chosen ... MoMA,s Celeste Bartos Theater during the daylong summit. Keynote ... of architecture and design, and Suzanne Lee , ...
(Date:6/23/2016)... 23, 2016 Apellis Pharmaceuticals, Inc. today ... trials of its complement C3 inhibitor, APL-2. The ... ascending dose studies designed to assess the safety, ... injection in healthy adult volunteers. Forty ... a single dose (ranging from 45 to 1,440mg) ...
(Date:6/23/2016)... Pleasant Prairie, WI (PRWEB) , ... June 23, ... ... sciences consultancy focused on quality, regulatory and technical consulting, provides a free ... webinar is presented on July 13, 2016 at 12pm CT at no charge. ...
Breaking Biology Technology:
(Date:6/15/2016)... June 15, 2016 Transparency ... titled "Gesture Recognition Market by Application Market - Global Industry Analysis ... 2024". According to the report, the  global gesture recognition ... 2015 and is estimated to grow at a ... by 2024.  Increasing application of gesture ...
(Date:6/2/2016)... 2016 The Department of Transport Management ... 44 million US Dollar project, for the , ... Personalization, Enrolment, and IT Infrastructure , to ... and implementation of Identity Management Solutions. Numerous renowned international vendors ... Decatur was selected for the most compliant and ...
(Date:5/20/2016)... 2016  VoiceIt is excited to announce its ... By working together, VoiceIt and VoicePass will ... VoicePass take slightly different approaches to voice biometrics, ... and usability. ... partnership. "This marketing and technology partnership ...
Breaking Biology News(10 mins):